Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of "Buy" from Brokerages
Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) has received a consensus recommendation of “Buy” from the ten research firms that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating on the company. […]